Carlos Alexandre Vieira

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1

Carlos Alexandre Vieira, Avinash Kumar Ágarwal, Benita K. Book et al. · Transplantation · 2004 · 268 citations

Rituximab Inhibits the In Vivo Primary and Secondary Antibody Response to a Neoantigen, Bacteriophage phiX174

Christopher M. Bearden, Avinash Kumar Ágarwal, Benita K. Book et al. · American Journal of Transplantation · 2005 · 91 citations

Secondary Antibody Response, Host Response, Microbial Pathogens +11

In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody

Richard A. Sidner, Benita K. Book, Avinash Kumar Ágarwal et al. · Human Antibodies · 2004 · 86 citations

Cell Therapy, Vivo Depletion, Immunology +19

Rituximab, Anti-CD20, Induces In Vivo Cytokine Release But Does Not Impair Ex Vivo T-Cell Responses

Avinash Kumar Ágarwal, Carlos Alexandre Vieira, Benita K. Book et al. · American Journal of Transplantation · 2004 · 57 citations · Full text

Clinical Immunology, T-regulatory Cell, Cellular Immunology +22

Can We Draw General Conclusions from Interval Training Studies?

Ricardo Borges Viana, Claudio André Barbosa de Lira, João Pedro Araújo Naves et al. · Sports Medicine · 2018 · 56 citations

Training System, Statistics, Interval Training Studies